| 000 | 01789 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515095008.0 | ||
| 264 | 0 | _c20080403 | |
| 008 | 200804s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm701186z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBell, Michael G | |
| 245 | 0 | 0 |
_a(S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cDec 2007 |
||
| 300 |
_a6443-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xchemical synthesis |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 |
_aIndoles _xchemical synthesis |
| 650 | 0 | 4 | _aMineralocorticoid Receptor Antagonists |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aSulfonamides _xchemical synthesis |
| 700 | 1 | _aGernert, Douglas L | |
| 700 | 1 | _aGrese, Timothy A | |
| 700 | 1 | _aBelvo, Matthew D | |
| 700 | 1 | _aBorromeo, Peter S | |
| 700 | 1 | _aKelley, Sally A | |
| 700 | 1 | _aKennedy, Joseph H | |
| 700 | 1 | _aKolis, Stanley P | |
| 700 | 1 | _aLander, Peter A | |
| 700 | 1 | _aRichey, Rachel | |
| 700 | 1 | _aSharp, V Scott | |
| 700 | 1 | _aStephenson, Gregory A | |
| 700 | 1 | _aWilliams, Jeffrey D | |
| 700 | 1 | _aYu, Hannah | |
| 700 | 1 | _aZimmerman, Karen M | |
| 700 | 1 | _aSteinberg, Mitchell I | |
| 700 | 1 | _aJadhav, Prabhakar K | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 50 _gno. 26 _gp. 6443-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm701186z _zAvailable from publisher's website |
| 999 |
_c17554219 _d17554219 |
||